These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10361109)

  • 1. Cladribine activity in adult langerhans-cell histiocytosis.
    Saven A; Burian C
    Blood; 1999 Jun; 93(12):4125-30. PubMed ID: 10361109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.
    Adam Z; Szturz P; Vaníček J; Moulis M; Pour L; Krejčí M; Hájek R; Mayer J
    Acta Oncol; 2013 Jun; 52(5):994-1001. PubMed ID: 22937955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
    Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
    Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
    Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J
    Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.
    Néel A; Artifoni M; Fontenoy AM; Tessoulin B; Lorillon G; Cohen-Aubart F; Haroche J; Genereau T; de Menthon M; Guillevin L; Maillard H; Kahn JE; Hermine O; Araujo C; Dromer C; Jullien D; Hamidou M; Donadieu J; Tazi A
    Br J Haematol; 2020 Jun; 189(5):869-878. PubMed ID: 32191819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis.
    Pardanani A; Phyliky RL; Li CY; Tefferi A
    Mayo Clin Proc; 2003 Mar; 78(3):301-6. PubMed ID: 12630583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
    Donadieu J; Bernard F; van Noesel M; Barkaoui M; Bardet O; Mura R; Arico M; Piguet C; Gandemer V; Armari Alla C; Clausen N; Jeziorski E; Lambilliote A; Weitzman S; Henter JI; Van Den Bos C;
    Blood; 2015 Sep; 126(12):1415-23. PubMed ID: 26194764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
    Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
    Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
    Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
    Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Langerhans cell histiocytosis with 2 chlorodeoxyadenosine.
    Dimopoulos MA; Theodorakis M; Kostis E; Papadimitris C; Moulopoulos LA; Anastasiou-Nana M
    Leuk Lymphoma; 1997 Mar; 25(1-2):187-9. PubMed ID: 9130627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine.
    Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V
    Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients].
    Grau J; Ribera JM; Tormo M; Indiano JM; Vercher J; Sandoval V; Ramírez G; Sastre A; Flores E; García-Conde J
    Med Clin (Barc); 2001 Mar; 116(9):339-42. PubMed ID: 11333766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia.
    Liu ES; Burian C; Miller WE; Saven A
    Br J Haematol; 1998 Dec; 103(3):690-5. PubMed ID: 9858218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
    Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.
    Stine KC; Saylors RL; Saccente S; McClain KL; Becton DL
    Pediatr Blood Cancer; 2004 Jul; 43(1):81-4. PubMed ID: 15170896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine.
    Büchler T; Cervinek L; Belohlavek O; Kantorova I; Mechl M; Nebesky T; Vorlicek J; Adam Z
    Pediatr Blood Cancer; 2005 Mar; 44(3):286-8. PubMed ID: 15481071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
    Yao X; Ying H; Weihong Z; Qing S; Xintian L
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.